Srdeční selhání s mírně sníženou ejekční frakcí - novinky ve farmakoterapii
| Title in English | Heart failure with mildly reduced ejection fraction - updates in pharmacotherapy |
|---|---|
| Authors | |
| Year of publication | 2023 |
| Type | Article in Periodical |
| Magazine / Source | Vnitrni Lekarstvi |
| MU Faculty or unit | |
| Citation | |
| Web | https://www.casopisvnitrnilekarstvi.cz/pdfs/vnl/2023/08/06.pdf |
| Doi | http://dx.doi.org/10.36290/vnl.2023.102 |
| Keywords | echocardiography; pharmacotherapy; gliflozins; heart failure with mildly reduced ejection fraction (HFmrEF). |
| Description | This review targets at patients suffering from heart failure with mildly reduced ejection fraction (HFmrEF). Diagnostic is briefly mentioned whereas pharmacotherapy is discused more due to significant changes in guidelines. New to therapy are gliflosins with AI recommendation. Also other therapy, such as angiotensin receptor blockers, beta blockers, mineralocorticoid blockers and diuretics are discussed below. Vericiguat and iron supplement therapy is described to complete the pharmacotherapeutic portfolio. |